NCT04453059View on ClinicalTrials.gov

Study With Oral Isovue in Abdominopelvic CT

CompletedOBSERVATIONAL
Enrollment

218

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Patients Requiring Abdominopelvic CT With Oral Administration of Contrast
Interventions
DRUG

Iopamidol

Previously administered Isovue-300 (300 mgI/mL) PO at a dilution of 2-3% (6-9 mgI/mL)

Trial Locations (1)

44308

Akron Children's Hospital, Akron

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY